Risk factors for chronic constipation and a possible role of analgesics

被引:66
作者
Chang, J. Y.
Locke, G. Richard
Schleck, C. D.
Zinsmeister, A. R.
Talley, N. J.
机构
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Gastroenterol & Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
acetaminophen; analgesics; constipation; risk factors;
D O I
10.1111/j.1365-2982.2007.00974.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Constipation has an estimated prevalence of 15% in the general population. However, the etiopathogenesis of this condition remains relatively obscure. This study sought to identify potentially novel risk factors for chronic constipation. A valid self-report questionnaire was mailed to an age-and gender-stratified random sample of Olmsted County, Minnesota residents aged 30-64 years. A logistic regression model that adjusted for age, gender and somatic symptom score (SSC) was used to identify factors associated with chronic constipation. People reporting symptoms of irritable bowel syndrome (IBS) were excluded. Of the 892 eligible subjects, 653 (73%) returned the survey. Among the 523 subjects not reporting IBS symptoms, chronic constipation was reported by 93 (18%) of the respondents. Chronic constipation was significantly associated with use of acetaminophen [7 tablets per week, OR = 2.7 (1.1 6.6)]; aspirin [OR = 1.7 (1.0-2.7)]; non-steroidal anti-inflammatory drugs [OR = 1.8 (1.1-3.0)]; and SSC. No association was detected for age, gender, body mass index, marital status, smoking, alcohol, coffee, education level, food allergy, exposure to pets, stress, emotional support, or water supply. Chronic constipation is associated with use of acetaminophen, aspirin and non-steroidal anti-inflammatory drugs. The explanation of these associations requires further investigation.
引用
收藏
页码:905 / 911
页数:7
相关论文
共 26 条
[1]
PSYCHOMETRIC PROPERTIES OF THE SUNYA REVISION OF THE PSYCHOSOMATIC SYMPTOM CHECKLIST [J].
ATTANASIO, V ;
ANDRASIK, F ;
BLANCHARD, EB ;
ARENA, JG .
JOURNAL OF BEHAVIORAL MEDICINE, 1984, 7 (02) :247-257
[2]
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study [J].
Bearcroft, CP ;
Perrett, D ;
Farthing, MJG .
GUT, 1998, 42 (01) :42-46
[3]
CAMILLERI M, 2000, LANCET, V55, P266
[4]
Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation [J].
Cash, BD ;
Chey, WD .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (11-12) :1047-1060
[5]
FISCHBACH FT, 1984, MANUAL LAB DIAGNOSTI, P160
[6]
Gershon Michael D, 2003, Rev Gastroenterol Disord, V3 Suppl 2, pS25
[7]
Epidemiology of constipation in North America: A systematic review [J].
Higgins, PDR ;
Johanson, JE .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (04) :750-759
[8]
CLINICAL EPIDEMIOLOGY OF CHRONIC CONSTIPATION [J].
JOHANSON, JF ;
SONNENBERG, A ;
KOCH, TR .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1989, 11 (05) :525-536
[9]
Effect of Tegaserod in Chronic Constipation: A Randomized, Double-Blind, Controlled Trial [J].
Johanson, John F. ;
Wald, Arnold ;
Tougas, Gervais ;
Chey, William D. ;
Novick, James S. ;
Lembo, Anthony J. ;
Fordham, Fiona ;
Guella, Mary ;
Nault, Brigitte .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (09) :796-805
[10]
JONES RH, 1995, BRIT J CLIN PRACT, V49, P67